PharmaRoth Labs, Inc. (ROTH)
PharmaRoth Labs, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3,512. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of -50.4%. Its beta of 1.83 implies it has historically moved more than the broad market.
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
PharmaRoth Labs, Inc. is most often compared with the following Healthcare names: